Entecavir

Description

Introducing Entecavir Tablets by PharmAlliance International Labs

At PharmAlliance International Labs, our mission is to pioneer innovative pharmaceutical solutions that redefine healthcare standards and empower patients worldwide. With a steadfast commitment to excellence, we are proud to introduce Entecavir Tablets, a testament to our dedication to enhancing the quality of life for individuals battling chronic hepatitis B virus (HBV) infection.

Drug Classification:

Entecavir belongs to the esteemed class of antiviral medications known as nucleoside analogs. Tailored to combat HBV replication, Entecavir exerts its therapeutic efficacy by inhibiting viral DNA synthesis, thereby curbing disease progression and fostering liver health.

Formulations:

Our Entecavir Tablets encapsulate precision and potency, containing 0.30 mg of the active ingredient, Entecavir, per tablet. This meticulously crafted formulation ensures accurate dosing and streamlined administration, facilitating patient adherence and therapeutic success.

Indications:

Entecavir Tablets stand as a beacon of hope for individuals grappling with chronic HBV infection. Indicated for use in adults and pediatric patients aged 2 years and older, Entecavir Tablets are recommended for those exhibiting active viral replication and evidence of liver disease activity.

Usage:

Administered orally, Entecavir Tablets offer unparalleled convenience and flexibility in treatment. Whether taken with or without food, adherence to prescribed dosage and administration instructions is paramount to optimizing therapeutic outcomes and mitigating disease progression.

Dosage:

Tailoring treatment to individual needs, the recommended dosage of Entecavir Tablets varies based on patient age and disease severity. From adults with compensated liver disease to pediatric patients and adults with decompensated liver function, healthcare providers determine the appropriate dosage regimen to ensure tailored care.

Side Effects:

While generally well-tolerated, Entecavir Tablets may elicit transient side effects such as headache, fatigue, nausea, diarrhea, dizziness, elevated liver enzymes, and insomnia. Vigilance in monitoring and reporting any adverse reactions to healthcare providers is essential to facilitate prompt intervention and support patient well-being.

Packaging Specifications:

Our commitment to patient-centric care extends to packaging, with Entecavir Tablets available in packs of 30. This generous supply ensures continuity of treatment and empowers patients on their journey towards liver health and wellness.

Trust PharmAlliance International Labs:

Embrace confidence in PharmAlliance International Labs for quality medications that transcend boundaries and make a tangible difference in the lives of those affected by hepatitis B. Through relentless innovation, unwavering research, and compassionate patient-centered care, we usher in a new era of healthcare excellence.